The CRISPR-associated protein Cas9 is an RNA-guided DNA endonuclease that uses RNA-DNA complementarity to identify target sites for sequence-specific double-stranded DNA (dsDNA) cleavage 1-5 . In its native context, Cas9 acts on DNA substrates exclusively because both binding and catalysis require recognition of a short DNA sequence, known as the protospacer adjacent motif (PAM), next to and on the strand opposite the twenty-nucleotide target site in dsDNA 4-7 . Cas9 has proven to be a versatile tool for genome engineering and gene regulation in a large range of prokaryotic and eukaryotic cell types, and in whole organisms 8 , but it has been thought to be incapable of targeting RNA 5 . Here we show that Cas9 binds with high affinity to single-stranded RNA (ssRNA) targets matching the Cas9-associated guide RNA sequence when the PAM is presented in trans as a separate DNA oligonucleotide. Furthermore, PAM-presenting oligonucleotides (PAMmers) stimulate site-specific endonucleolytic cleavage of ssRNA targets, similar to PAM-mediated stimulation of Cas9catalysed DNA cleavage 7 . Using specially designed PAMmers, Cas9 can be specifically directed to bind or cut RNA targets while avoiding corresponding DNA sequences, and we demonstrate that this strategy enables the isolation of a specific endogenous messenger RNA from cells. These results reveal a fundamental connection between PAM binding and substrate selection by Cas9, and highlight the utility of Cas9 for programmable transcript recognition without the need for tags.
targets in the presence of a short PAMpresenting DNA oligonucleotide (PAMmer). a, Schematic depicting the approach used to target ssRNA for programmable, sequence-specific cleavage. b, The panel of nucleic acid substrates examined in this study. Substrate elements are coloured as follows: DNA, grey; RNA, black; guide-RNA target sequence, red; DNA PAM, yellow; mutated DNA PAM, blue; RNA PAM, orange. The 18-nucleotide 'GG PAMmer' contains only a GG dinucleotide PAM sequence. nt, nucleotide. c, Representative cleavage assay for 59-radiolabelled nucleic acid substrates using Cas9-gRNA, numbered as in b. d, Cas9-gRNA cleavage site mapping assay for substrate 3. T1 and OH 2 denote RNase T1 and hydrolysis ladders, respectively; the sequence of the target ssRNA is shown at right. Sites of G cleavage by RNase T1 are shown at left. Site of Cas9 cleavage (G24) shown at right. e, Representative ssRNA cleavage assay in the presence of PAMmers of increasing length, numbered as in b.
( Fig. 1b and Extended Data Table 1 ). Deoxyribonucleotide-comprised PAMmers specifically activated Cas9 to cleave ssRNA ( Fig. 1c) , an effect that required a 59-NGG-39 or 59-GG-39 PAM. RNA cleavage was not observed using ribonucleotide-based PAMmers, suggesting that Cas9 may recognize the local helical geometry and/or deoxyribose moieties within the PAM. Consistent with this hypothesis, dsRNA targets were not cleavable and RNA-DNA heteroduplexes could only be cleaved when the non-target strand was composed of deoxyribonucleotides. Notably, we found that Cas9 cleaved the ssRNA target strand between positions 4 and 5 of the base-paired gRNA-target-RNA hybrid ( Fig. 1d ), in contrast to the cleavage between positions 3 and 4 observed for dsDNA [3] [4] [5] . This is probably due to subtle differences in substrate positioning. However, we did observe a significant reduction in the pseudo-first-order cleavage rate constant of PAMmer-activated ssRNA as compared to ssDNA 7 (Extended Data Fig. 1 ).
We hypothesized that PAMmer nuclease activation would depend on the stability of the hybridized PAMmer-ssRNA duplex and tested this by varying PAMmer length. As expected, ssRNA cleavage was lost when the predicted melting temperature for the duplex decreased below the temperature used in our experiments ( Fig. 1e ). In addition, large molar excesses of di-or tri-deoxyribonucleotides in solution were poor activators of Cas9 cleavage (Extended Data Fig. 2 ). Collectively, these data demonstrate that hybrid substrate structures composed of ssRNA and deoxyribonucleotide-based PAMmers that anneal upstream of the RNA target sequence can be cleaved efficiently by RNA-guided Cas9.
We investigated the binding affinity of catalytically inactive dCas9 (Cas9 (D10A;H840A))-gRNA for ssRNA targets with and without PAMmers using a gel mobility shift assay. Notably, whereas our previous results showed that ssDNA and PAMmer-activated ssDNA targets are bound with indistinguishable affinity 7 , PAMmer-activated ssRNA targets were bound .500-fold tighter than ssRNA alone ( Fig. 2a, b) . A recent crystal structure of Cas9 bound to a ssDNA target revealed deoxyribose-specific van der Waals interactions between the protein and the DNA backbone 13 , suggesting that energetic penalties associated with ssRNA binding must be attenuated by favourable compensatory binding interactions with the provided PAM. The equilibrium dissociation constant measured for a PAMmer-ssRNA substrate was within fivefold of that for dsDNA ( Fig. 2b ), and this high-affinity interaction again required a cognate deoxyribonucleotide-comprised 59-GG-39 PAM ( Fig. 2a ). Tight binding also scaled with PAMmer length (Fig. 2c ), consistent with the cleavage data presented above.
It is known that Cas9 possesses an intrinsic affinity for RNA, but sequence specificity of the interaction had not been explored 5 . Thus, to verify the programmable nature of PAMmer-mediated ssRNA cleavage by Cas9-gRNA, we prepared three distinct guide RNAs (l2, l3 and l4; each targeting 20-nucleotide sequences within l2, l3 and l4 RNAs, respectively) and showed that their corresponding ssRNA targets could be efficiently cleaved using complementary PAMmers without any detectable cross-reactivity ( Fig. 3a ). This result indicates that complementary RNA-RNA base pairing is critical in these reactions. Notably however, dCas9 programmed with the l2 guide RNA bound all three PAMmer-ssRNA substrates with similar affinity (Fig. 3b ). This observation suggests that high-affinity binding in this case may not require correct base pairing between the guide RNA and the ssRNA target, particularly given the compensatory role of the PAMmer.
During dsDNA targeting by Cas9-gRNA, duplex melting proceeds directionally from the PAM and strictly requires the formation of complementary RNA-DNA base pairs to offset the energetic costs associated with dsDNA unwinding 7 . We therefore wondered whether binding specificity for ssRNA substrates would be recovered using PAMmers containing 59-extensions that create a partially double-stranded target region requiring unwinding ( Fig. 3c ). We found that use of a 59-extended PAMmer enabled dCas9 bearing the l2 guide sequence to bind sequenceselectively to the l2 PAMmer-ssRNA target. The l3 and l4 PAMmer-ssRNA targets were not recognized ( Fig. 3d and Extended Data Fig. 3 ), binding. a, Cas9 programmed with either l2-, l3or l4-targeting gRNAs exhibits sequence-specific cleavage of 59-radiolabelled l2, l3 and l4 target ssRNAs, respectively, in the presence of cognate PAMmers. b, dCas9 programmed with a l2-targeting gRNA exhibits similar binding affinity to l2, l3 and l4 target ssRNAs in the presence of cognate PAMmers. Dissociation constants from three independent experiments (mean 6 s.d.) were 0.20 6 0.09 nM (l2), 0.33 6 0.14 nM (l3) and 0.53 6 0.21 nM (l4). c, Schematic depicting the approach used to restore gRNA-mediated ssRNA binding specificity, which involves 59-extensions to the PAMmer that cover part or all of the target sequence. d, dCas9 programmed with a l2-targeting gRNA specifically binds the l2 ssRNA but not l3 and l4 ssRNAs in the presence of complete 59-extended PAMmers. Dissociation constants from three independent experiments (mean 6 s.d.) were 3.3 6 1.2 nM (l2) and .100 nM (l3 and l4).
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although we did observe a tenfold reduction in overall ssRNA substrate binding affinity. By systematically varying the length of the 59 extension, we found that PAMmers containing 2-8 additional nucleotides upstream of the 59-NGG-39 offer an optimal compromise between gains in binding specificity and concomitant losses in binding affinity and cleavage efficiency (Extended Data Fig. 4 ).
Next we investigated whether nuclease activation by PAMmers requires base pairing between the 59-NGG-39 and corresponding nucleotides on the ssRNA. Prior studies have shown that DNA substrates containing a cognate PAM that is mismatched with the corresponding nucleotides on the target strand are cleaved as efficiently as a fully base-paired PAM 4 . This could enable targeting of RNA while precluding binding or cleavage of corresponding genomic DNA sites lacking PAMs (Fig. 4a ). To test this possibility, we first demonstrated that Cas9-gRNA cleaves PAMmer-ssRNA substrates regardless of whether or not the PAM is base paired (Fig. 4b, c ). When Cas9-RNA was incubated with both a PAMmer-ssRNA substrate and the corresponding dsDNA template containing a cognate PAM, both targets were cleaved. In contrast, when a dsDNA target lacking a PAM was incubated together with a PAMmer-ssRNA substrate bearing a mismatched 59-NGG-39 PAM, Cas9-gRNA selectively targeted the ssRNA for cleavage ( Fig. 4c ). The same result was obtained using a mismatched PAMmer with a 59 extension ( Fig. 4c ), demonstrating that this general strategy enables the specific targeting of RNA transcripts while effectively eliminating any targeting of their corresponding dsDNA template loci.
We next explored whether Cas9-mediated RNA targeting could be applied in tagless transcript isolation from HeLa cells (Fig. 4d) . The immobilization of Cas9 on a solid-phase resin is described in Methods (see also Extended Data Fig. 5 ). As a proof of concept, we first isolated GAPDH mRNA from HeLa total RNA using biotinylated dCas9, gRNAs and PAMmers (Extended Data Table 2 ) that target four non-PAM-adjacent sequences within exons 5-7 (Fig. 4e ). We observed a substantial enrichment of GAPDH mRNA relative to control b-actin mRNA by northern blot analysis, but saw no enrichment using a non-targeting gRNA or dCas9 alone (Fig. 4f) .
We then used this approach to isolate endogenous GAPDH transcripts from HeLa cell lysate under physiological conditions. In initial experiments, we found that Cas9-gRNA captured two GAPDH-specific RNA fragments rather than the full-length mRNA (Fig. 4g ). Based on the sizes of these bands, we hypothesized that RNA-DNA heteroduplexes formed between the mRNA and PAMmer were cleaved by cellular RNase H. Previous studies have shown that modified DNA oligonucleotides can abrogate RNase H activity 14 , and therefore we investigated whether Cas9 would tolerate chemical modifications to the PAMmer. We found that a wide range of modifications (locked nucleic acids, 29-OMe and 29-F ribose moieties) still enabled PAMmer-mediated nuclease 
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activation (Extended Data Fig. 6 ). Furthermore, by varying the pattern of 29-OMe modifications in the PAMmer, we could completely eliminate RNase-H-mediated cleavage during the pull-down and successfully isolate intact GAPDH mRNA (Fig. 4g, h) . Notably, we consistently observed specific isolation of GAPDH mRNA in the absence of any PAMmer, albeit with lower efficiency, suggesting that Cas9-gRNA can bind to GAPDH mRNA through direct RNA-RNA hybridization (Fig. 4f, g and Extended Data Fig. 7) . These experiments demonstrate that RNAguided Cas9 can be used to purify endogenous untagged RNA transcripts. In contrast to current oligonucleotide-mediated RNA-capture methods, this approach works well under physiological salt conditions and does not require crosslinking or large sets of biotinylated probes [15] [16] [17] .
Here we have demonstrated the ability to re-direct the dsDNA targeting capability of CRISPR/Cas9 for RNA-guided ssRNA binding and/or cleavage (which we now denote RCas9, an RNA-targeting Cas9). Programmable RNA recognition and cleavage has the potential to transform the study of RNA function, much as site-specific DNA targeting is changing the landscape of genetic and genomic research 8 (Extended Data Fig. 8 ). Although certain engineered proteins such as PPR proteins and Pumilio/FBF (PUF) repeats show promise as platforms for sequence-specific RNA targeting [18] [19] [20] [21] [22] , these strategies require re-designing the protein for every new RNA sequence of interest. While RNA interference has proven useful for manipulating gene regulation in certain organisms 23 , there has been a strong motivation to develop orthogonal nucleic-acid-based RNA recognition systems, such as the CRISPR/Cas Type III-B Cmr complex [24] [25] [26] [27] [28] and the atypical Cas9 from Francisella novicida 29, 30 . In contrast to these systems, the molecular basis for RNA recognition by RCas9 is now clear and requires only the design and synthesis of a matching gRNA and complementary PAMmer. The ability to recognize endogenous RNAs within complex mixtures with high affinity and in a programmable manner paves the way for direct transcript detection, analysis and manipulation without the need for genetically encoded affinity tags.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Cas9 and nucleic acid preparation. Wild-type Cas9 and catalytically inactive dCas9 (Cas9(D10A;H840A)) from S. pyogenes were purified as previously described 4 . Fortytwo-nucleotide crRNAs were either ordered synthetically (Integrated DNA Technologies) or transcribed in vitro with T7 polymerase using single-stranded DNA templates, as described 31 . Using the previously described numbering scheme 4 , tracrRNA was transcribed in vitro and contained nucleotides 15-87. Single-guide RNAs (sgRNAs) targeting l-RNAs were transcribed in vitro from linearized plasmids and contain full-length crRNA and tracrRNA connected via a GAAA tetraloop insertion. GAPDH mRNA-targeting sgRNAs were transcribed in vitro from dsDNA PCR products based on an optimized sgRNA design 32 . Target ssRNAs (55-56 nucleotides) were transcribed in vitro using single-stranded DNA templates. Sequences of all nucleic acid substrates used in this study can be found in Extended Data Tables 1 and 2. All RNAs were purified using 10-15% denaturing polyacrylamide gel electrophoresis (PAGE). Duplexes of crRNA and tracrRNA were prepared by mixing equimolar concentrations of each RNA in hybridization buffer (20 mM Tris-HCl, pH 7.5, 100 mM KCl, 5 mM MgCl 2 ), heating to 95 uC for 30 s and slow cooling. Fully doublestranded DNA/RNA substrates (substrates 1, 8-10 in Fig. 1 and substrates 1 and 2 in Fig. 4) were prepared by mixing equimolar concentrations of each nucleic acid strand in hybridization buffer, heating to 95 uC for 30 s, and slow cooling. RNA, DNA and chemically modified PAMmers were synthesized commercially (Intergrated DNA Technologies). DNA and RNA substrates were 59-radiolabelled using [c-32 P]ATP (PerkinElmer) and T4 polynucleotide kinase (New England Biolabs). Double-stranded DNA and dsRNA substrates (Figs 1c and 4c) were 59-radiolabelled on both strands, whereas only the target ssRNA was 59-radiolabelled in other experiments. Cleavage assays. Cas9-gRNA complexes were reconstituted before cleavage experiments by incubating Cas9 and the crRNA-tracrRNA duplex for 10 min at 37 uC in reaction buffer (20 mM Tris-HCl, pH 7.5, 75 mM KCl, 5 mM MgCl 2 , 1 mM dithiothreitol (DTT), 5% glycerol). Cleavage reactions were conducted at 37 uC and contained ,1 nM 59-radiolabelled target substrate, 100 nM Cas9-RNA, and 100 nM PAMmer, where indicated. Aliquots were removed at each time point and quenched by the addition of RNA gel-loading buffer (95% deionized formamide, 0.025% (w/v) bromophenol blue, 0.025% (w/v) xylene cyanol, 50 mM EDTA (pH 8.0), 0.025% (w/v) SDS). Samples were boiled for 10 min at 95 uC before being resolved by 12% denaturing PAGE. Reaction products were visualized by phosphorimaging and quantified with ImageQuant (GE Healthcare). RNA cleavage site mapping. A hydrolysis ladder (OH 2 ) was obtained by incubating ,25 nM 59-radiolabelled l2 target ssRNA in hydrolysis buffer (25 mM CAPS (N-cyclohexyl-3-aminopropanesulphonic acid), pH 10.0, 0.25 mM EDTA) at 95 uC for 10 min, before quenching on ice. An RNase T1 ladder was obtained by incubating ,25 nM 59-radiolabelled l2 target ssRNA with 1 U RNase T1 (New England Biolabs) for 5 min at 37 uC in RNase T1 buffer (20 mM sodium citrate, pH 5.0, 1 mM EDTA, 2 M urea, 0.1 mg ml 21 yeast transfer RNA). The reaction was quenched by phenol/chloroform extraction before adding RNA gel-loading buffer. All products were resolved by 15% denaturing PAGE. Electrophoretic mobility shift assays. In order to avoid dissociation of the Cas9-gRNA complex at low concentrations during target ssRNA binding experiments, binding reactions contained a constant excess of dCas9 (300 nM), increasing concentrations of sgRNA, and 0.1-1 nM of target ssRNA. The reaction buffer was supplemented with 10 mg ml 21 heparin in order to avoid non-specific association of apo-dCas9 with target substrates 7 . Reactions were incubated at 37 uC for 45 min before being resolved by 8% native PAGE at 4 uC (0.53 TBE buffer with 5 mM MgCl 2 ). RNA and DNA were visualized by phosphorimaging, quantified with ImageQuant (GE Healthcare), and analysed with Kaleidagraph (Synergy Software).
Cas9 biotin labelling. To ensure specific labelling at a single residue on Cas9, two naturally occurring cysteine residues were mutated to serine (C80S and C574S) and a cysteine point mutant was introduced at residue Met 1. To attach the biotin moiety, 10 mM wild-type Cas9 or dCas9 was reacted with a 50-fold molar excess of EZ-Link Maleimide-PEG2-Biotin (Thermo Scientific) at 25 uC for 2 h. The reaction was quenched by the addition of 10 mM DTT, and unreacted Maleimide-PEG2-Biotin was removed using a Bio-Gel P-6 column (Bio-Rad). Labelling was verified using a streptavidin bead binding assay, where 8.5 pmol of biotinylated Cas9 or non-biotinylated Cas9 was mixed with either 25 ml streptavidin-agarose (Pierce Avidin Agarose; Thermo Scientific) or 25 ml streptavidin magnetic beads (Dynabeads MyOne Streptavidin C1; Life Technologies). Samples were incubated in Cas9 reaction buffer at room temperature for 30 min, followed by three washes with Cas9 reaction buffer and elution in boiling SDS-PAGE loading buffer. Elutions were analysed using SDS-PAGE. Cas9 M1C biotinylation was also confirmed using mass spectroscopy performed in the QB3/Chemistry Mass Spectrometry Facility at UC Berkeley. Samples of intact Cas9 proteins were analysed using an Agilent 1200 liquid chromatograph equipped with a Viva C8 (100 mm 3 1.0 mm, 5 mm particles, Restek) analytical column and connected in-line with an LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific). Mass spectra were recorded in the positive ion mode. Mass spectral deconvolution was performed using ProMass software (Novatia). GAPDH mRNA pull-down. HeLa-S3 cell lysates were prepared as previously described 33 . Total RNA was isolated from HeLa-S3 cells using Trizol reagent according to the manufacturer's instructions (Life Technologies). Cas9-sgRNA complexes were reconstituted before pull-down experiments by incubating a twofold molar excess of Cas9 with sgRNA for 10 min at 37 uC in reaction buffer. HeLa total RNA (40 mg) or HeLa lysate (,5 3 10 6 cells) was added to reaction buffer with 40 U RNasin (Promega), PAMmer (5 mM) and the biotin-dCas9 (50 nM)-sgRNA (25 nM) in a total volume of 100 ml and incubated at 37 uC for 1 h. This mixture was then added to 25 ml magnetic streptavidin beads (Dynabeads MyOne Streptavidin C1; Life Technologies) pre-equilibrated in reaction buffer and agitated at 4 uC for 2 h. Beads were then washed six times with 300 ml wash buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl 2, 0.1% Triton X-100, 5% glycerol, 1 mM DTT, 10 mg ml 21 heparin). Immobilized RNA was eluted by heating beads at 70 uC in the presence of DEPC-treated water and a phenol/chloroform mixture. Eluates were then treated with an equal volume of glyoxal loading dye (Life Technologies) and heated at 50 uC for 1 h before separation via 1% BPTE agarose gel (30 mM Bis-Tris, 10 mM PIPES, 10 mM EDTA, pH 6.5). Northern blot transfers were carried out as previously described 34 . Following transfer, membranes were crosslinked using UV radiation and incubated in pre-hybridization buffer (UltraHYB Ultrasensitive Hybridization Buffer; Life Technologies) for 1 h at 46 uC before hybridization. Radioactive northern probes were synthesized using random priming of GAPDH and b-actin partial cDNAs (for cDNA primers, see Extended Data Table 2 ) in the presence of [a-32 P]dATP (PerkinElmer), using a Prime-It II Random Primer Labelling kit (Agilent Technologies). Hybridization was carried out for 3 h in pre-hybridization buffer at 46 uC followed by two washes with 2 3 SSC (300 mM NaCl, 30 mM trisodium citrate, pH 7, 0.5% (w/v) SDS) for 15 min at 46 uC. Membranes were imaged using a phosphorscreen. Gel shift assays were conducted as described in the Methods. Binding reactions contained Cas9 programmed with l2 gRNA and either l2 (on-target), l3 (off-target) or l4 (off-target) ssRNA in the presence of short cognate PAMmers or cognate PAMmers with complete 59-extensions, as indicated. The presence of a cognate 59-extended PAM-mer abrogates off-target binding. Three independent experiments were conducted to produce the data shown in Fig. 3b, d .
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